Concepedia

Zayani Sims

ZS

Statistics

Publications

10

Citations

964

H-Index

10

Active since

2014

Affiliations

Gilead Sciences (United States)(Current)

University of Maryland, Baltimore

National Institutes of Health

National Institute of Allergy and Infectious Diseases

National Institutes of Health Clinical Center

Zayani Sims is an author at Gilead Sciences (United States) specializing in epidemiology, viral hepatitis, and hepatitis c.

Top concepts

Publications per year

2014–2016

10

Publications

10

Virologic Response Following Combined Ledipasvir and Sofosbuvir Administration in Patients With HCV Genotype 1 and HIV Co-infection

Anu Osinusi, Kerry Townsend, Anita Kohli et al. · JAMA · 2015 · 203 citations · Full text

Ledipasvir and sofosbuvir for hepatitis C genotype 4: a proof-of-concept, single-centre, open-label phase 2a cohort study

Anita Kohli, Rama Kapoor, Zayani Sims et al. · The Lancet Infectious Diseases · 2015 · 165 citations · Full text

, , +11

Effect of sofosbuvir and ribavirin treatment on peripheral and hepatic lipid metabolism in chronic hepatitis C virus, genotype 1–infected patients

Eric G. Meissner, Y.-J. Lee, Anu Osinusi et al. · Hepatology · 2014 · 157 citations · Full text

Virological response after 6 week triple-drug regimens for hepatitis C: a proof-of-concept phase 2A cohort study

Anita Kohli, A. Osinusi, Zayani Sims et al. · The Lancet · 2015 · 151 citations

, , +9

Utility of Hepatitis C Viral Load Monitoring on Direct-Acting Antiviral Therapy

Sreetha Sidharthan, Anita Kohli, Zayani Sims et al. · Clinical Infectious Diseases · 2015 · 101 citations · Full text

1–5 of 10